US8273341 — Antiviral compounds
Method of Use · Assigned to Gilead Sciences Inc · Expires 2030-05-12 · 4y remaining
What this patent protects
This patent protects anti-viral compounds, compositions containing them, and therapeutic methods for their administration, as well as processes and intermediates for preparing these compounds.
USPTO Abstract
The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
Drugs covered by this patent
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-1470 |
— | |
U-1470 |
— | |
U-1470 |
— | |
U-1470 |
— |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.